This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Apr;3(4):EVIDe2400011.

doi: 10.1056/EVIDe2400011. Epub 2024 Mar 26.

Reflecting the Real World of Cancer Care - The Impact of Broadening Trial Eligibility

Ramya Ramaswami¹, Thomas S Uldrick²

Affiliations

Affiliations

¹ HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
² Fred Hutchinson Cancer Center, Seattle.

PMID: 38772003
DOI: 10.1056/EVIDe2400011

Editorial

Reflecting the Real World of Cancer Care - The Impact of Broadening Trial Eligibility

Ramya Ramaswami et al. NEJM Evid. 2024 Apr.

. 2024 Apr;3(4):EVIDe2400011.

doi: 10.1056/EVIDe2400011. Epub 2024 Mar 26.

Authors

Ramya Ramaswami¹, Thomas S Uldrick²

Affiliations

¹ HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
² Fred Hutchinson Cancer Center, Seattle.

PMID: 38772003
DOI: 10.1056/EVIDe2400011

No abstract available

PubMed Disclaimer

Comment on

Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
Kaur M, Frahm F, Lu Y, Ascha MS, Guadamuz JS, Dotan E, Gottesman AS, Leybovich BC, Sondhi A, Zhao Y, Meropol NJ, Royce TJ. Kaur M, et al. NEJM Evid. 2024 Apr;3(4):EVIDoa2300236. doi: 10.1056/EVIDoa2300236. Epub 2024 Mar 26. NEJM Evid. 2024. PMID: 38771994

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information